arBtrage CAPITALIZING MARKETS — checking… Sign in Sign up
Calendar /

NRC Health

NRC Health Care Biotechnology: Commercial Physical & Biological Resarch
$21.38
▲ +3.3% Today
as of Oct 22, 16:50 ET
Last 30 days -4.17% Sep 14 → Oct 22
$19.35 $20.15 $20.94 $21.73 $22.53 Sep 14 Sep 22 Sep 29 Oct 07 Oct 14 Oct 22
Open
$20.32
High
$21.43
Low
$20.32
Volume
$70,067
Avg Vol
$108,831
Mkt Cap
$447M
P/E (TTM)
118.53
Beta
—
52w High
$23.68
52w Low
$11.32
Div Yield
—
Shares Out
$22M

Recent Press Releases & News last 60 days · 5 items

Oct 15 · 20:53 PR Business Wire
New NRC Health Research Reveals What Sets High-Performing Health Systems Apart: Turning Patient Feedback Into Action
Sep 28 · 16:35 Zacks
NRC Health Trades at a Discount: Should You Buy, Sell or Hold?
Sep 25 · 11:04 GuruFocus.com
NRC Health's Dividend Analysis
▸ Show all 5 press releases & news Free account →

NRC earnings at a glance

NRC Health (NRC) is scheduled to report earnings on Monday, October 26, 2026 — in 3 days. Analysts expect earnings per share of $0.21, compared with $0.23 in the same quarter last year (-9%). The options market is pricing a move of about ±4.8% after the report, a range of roughly $20.36 to $22.40 from today's $21.38. Over its last 3 reports the stock rose the next day 2 times and fell 1, moving ±10.1% on average; after the most recent report on Oct 27, 2025 it moved +16.0%. That means options currently expect less movement than NRC has typically delivered. Implied volatility is currently 40%. The share price of $21.38 sits near its 52-week high.

More Health Care stocks · All stocks · Earnings calendar

Overview

52-week range
$11
$24
81% of range
Avg surprise (last 0)
—
Avg reaction (last 3)
+6.9%
67% positive
Latest IV / EM
40%
EM ±4.8% · $20 · Oct 16

Earnings trends

EPS — actual vs estimate Actual Estimate
$-0.15$-0.03$0.08$0.20$0.32 Actual $0.28Actual $0.29Actual $0.32Actual $0.27Actual $0.26Actual $0.24Actual $0.25Actual $0.28Actual $0.23Actual $0.14Actual $-0.15 MarJunSepMarJunSepMar/2025Jun/2025Sep/2025MarJun
Revenue vs Net Income Revenue Net income
$-3M$7M$17M$27M$38M Sep 24Mar 25Jun 25Sep 25Mar 26Jun 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Tue Jun 30, 2026Jun 2026 $-0.15 — — — — financials
Tue Mar 31, 2026Mar 2026 $0.14 — — — — financials
Mon Oct 27, 2025Sep/2025 $0.23 — — — +16.0% earnings
Mon Jul 28, 2025Jun/2025 $0.28 — — — -4.8% earnings
Mon Apr 28, 2025Mar/2025 $0.25 — — — +9.5% earnings
Mon Sep 30, 2024Sep 2024 $0.24 — — — — financials
Sun Jun 30, 2024Jun 2024 $0.26 — — — — financials
Sun Mar 31, 2024Mar 2024 $0.27 — — — — financials
Sat Sep 30, 2023Sep 2023 $0.32 — — — — financials
Fri Jun 30, 2023Jun 2023 $0.29 — — — — financials
Fri Mar 31, 2023Mar 2023 $0.28 — — — — financials

Upcoming

DateFiscalTimeEPS EstLY EPSYoY %Δ
Mon Oct 26, 2026Sep/2026OTHER $0.21$0.23 -8.7%

Financials

Income statement (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue$35M$35M—$35M$34M$34M—$36M
Cost of revenue————————
Gross profit————————
Operating income$-3M$6M—$8M$2M$9M—$8M
Net income$-3M$3M—$4M$-106,000$6M—$6M
EPS (diluted)$-0.15$0.14—$0.18$-0.01$0.25—$0.24

Balance sheet (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Cash & equivalents$3M$3M$4M$2M$5M$3M$4M$3M
Inventory————————
Total current assets$23M$20M$20M$20M$25M$20M$20M$21M
Total assets$136M$135M$135M$136M$141M$135M$133M$132M
Long-term debt$86M$74M$75M$76M$77M$59M$58M$45M
Total liabilities$130M$121M$121M$121M$120M$106M$101M$97M
Total equity$7M$13M$14M$14M$21M$30M$31M$35M

Implied volatility — last 90 days

16%70%124%177%231% Jun 07 — IV 49% · EM ±6.8%Jun 08 — IV 45% · EM ±5.9%Jun 09 — IV 40% · EM ±5.1%Jun 10 — IV 101% · EM ±12.0%Jun 11 — IV 123% · EM ±13.6%Jun 12 — IV 232% · EM ±23.7%Jun 15 — IV 147% · EM ±10.7%Jun 16 — IV 188% · EM ±11.1%Jun 17 — IV 108% · EM ±4.5%Jun 19 — IV 42% · EM ±9.3%Jun 22 — IV 39% · EM ±8.2%Jun 23 — IV 37% · EM ±7.5%Jun 24 — IV 39% · EM ±7.7%Jun 25 — IV 37% · EM ±7.3%Jun 26 — IV 43% · EM ±8.3%Jun 29 — IV 37% · EM ±6.6%Jun 30 — IV 40% · EM ±7.0%Jul 01 — IV 36% · EM ±6.0%Jul 02 — IV 32% · EM ±5.1%Jul 03 — IV 33% · EM ±5.1%Jul 06 — IV 29% · EM ±4.0%Jul 07 — IV 33% · EM ±4.4%Jul 08 — IV 40% · EM ±5.0%Jul 09 — IV 101% · EM ±12.0%Jul 10 — IV 82% · EM ±9.0%Jul 13 — IV 80% · EM ±6.6%Jul 14 — IV 72% · EM ±5.2%Jul 16 — IV 109% · EM ±4.6%Jul 20 — IV 45% · EM ±10.6%Jul 21 — IV 44% · EM ±10.2%Jul 22 — IV 44% · EM ±10.1%Jul 23 — IV 47% · EM ±10.6%Jul 24 — IV 49% · EM ±10.8%Jul 27 — IV 50% · EM ±10.3%Jul 28 — IV 42% · EM ±8.6%Jul 29 — IV 46% · EM ±9.3%Jul 30 — IV 43% · EM ±8.5%Jul 31 — IV 39% · EM ±7.4%Aug 03 — IV 44% · EM ±7.8%Aug 04 — IV 43% · EM ±7.4%Aug 05 — IV 41% · EM ±6.8%Aug 06 — IV 41% · EM ±6.7%Aug 07 — IV 36% · EM ±5.7%Aug 10 — IV 48% · EM ±6.6%Aug 11 — IV 47% · EM ±6.2%Aug 12 — IV 48% · EM ±6.1%Aug 13 — IV 97% · EM ±11.5%Aug 14 — IV 107% · EM ±11.8%Aug 17 — IV 76% · EM ±6.3%Aug 18 — IV 47% · EM ±3.4%Aug 19 — IV 50% · EM ±3.0%Aug 20 — IV 17% · EM ±0.7%Aug 24 — IV 39% · EM ±8.2%Aug 25 — IV 39% · EM ±7.9%Aug 26 — IV 38% · EM ±7.6%Aug 27 — IV 38% · EM ±7.5%Aug 28 — IV 36% · EM ±7.0%Aug 31 — IV 46% · EM ±8.2%Sep 01 — IV 43% · EM ±7.3%Sep 02 — IV 37% · EM ±6.1%Sep 03 — IV 51% · EM ±8.2%Sep 04 — IV 50% · EM ±7.8%Sep 07 — IV 56% · EM ±7.8%Sep 08 — IV 62% · EM ±8.1%Sep 09 — IV 57% · EM ±7.2%Sep 10 — IV 57% · EM ±6.7%Sep 11 — IV 62% · EM ±6.9%Sep 14 — IV 44% · EM ±3.7%Sep 15 — IV 60% · EM ±4.3%Sep 16 — IV 52% · EM ±3.1%Sep 17 — IV 218% · EM ±9.1%Sep 21 — IV 47% · EM ±9.8%Sep 22 — IV 41% · EM ±8.3%Sep 23 — IV 43% · EM ±8.6%Sep 24 — IV 41% · EM ±8.0%Sep 25 — IV 41% · EM ±7.8%Sep 28 — IV 42% · EM ±7.5%Sep 29 — IV 48% · EM ±8.2%Sep 30 — IV 49% · EM ±8.3%Oct 01 — IV 44% · EM ±7.2%Oct 02 — IV 39% · EM ±6.0%Oct 06 — IV 38% · EM ±5.0%Oct 07 — IV 39% · EM ±4.8%Oct 08 — IV 40% · EM ±4.8%

Sector peers

OABI
OmniAb, Inc.
$663M $4.78-3.6%
MXCT
MaxCyte, Inc.
$112M $1.430.0%
ONMD
OneMedNet Corp
$33M $4.91+3.4%
NOTV
Inotiv, Inc.
$10M $0.08
BIAF
bioAffinity Technologies, Inc.
$7M $3.17-13.4%
ISPC
iSpecimen Inc.
$6M $0.83-13.3%

NRC earnings FAQ

When is NRC's next earnings date?

NRC Health is expected to report on October 26, 2026.

What is NRC's expected move for earnings?

Options currently price a move of about ±4.8%, or $1.02 per share either way from $21.38.

How does NRC stock usually react to earnings?

Across the last 3 reports the average next-day move was ±10.1%, up 2 times and down 1 times.

What EPS are analysts expecting from NRC Health?

The consensus estimate is $0.21 per share, versus $0.23 a year ago.

What is NRC's implied volatility?

NRC's at-the-money implied volatility is about 40% based on the latest options snapshot.

View on Nasdaq ↗
🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.
Sign up free → Sign in